Fewer Prevnar jabs just as effective

A new study demonstrates that three doses of Wyeth's pneumococcal vaccine Prevnar works as well as the four-dose regimen currently in use. And a reduction in jabs could save payers a significant amount of money. "In my opinion you could safely go to two-plus-one," Elisabeth Sanders, one of the study's co-authors, told Dow Jones. "Why not save the one injection if it's not required?" Report